Yong Teng

Yong Teng is an esteemed Associate Professor in the Coulter Department of Biomedical Engineering, a collaborative program between Emory University and the Georgia Institute of Technology. With a profound dedication to advancing cancer research, Dr. Teng's work primarily revolves around understanding the intricate mechanisms that drive cancer progression and influence treatment responses. His research is particularly focused on the development of targeted and immune-based cancer therapeutics, aiming to revolutionize the way cancer is treated. Dr. Teng employs cutting-edge methodologies, including novel 3D culture systems and preclinical animal models, to delve deep into the molecular mechanisms of cancer metastasis, metabolism, and immunogenic cell death. His innovative approach allows for a comprehensive understanding of how tumors develop resistance to treatments, a critical challenge in oncology. By exploring these pathways, Dr. Teng seeks to uncover new anticancer strategies that not only induce tumor regression but also enhance the body's antitumor immune response. In his pursuit of groundbreaking therapies, Dr. Teng's laboratory is at the forefront of developing tumor-seeking nanomedicines, therapeutic stapled peptides, and oncolytic viruses. These advanced therapeutic modalities are designed to improve the efficacy of cancer treatments, offering hope for more targeted and effective interventions. His work is characterized by a commitment to translating scientific discoveries into practical applications that can benefit patients. Dr. Teng's research interests are deeply rooted in the exploration of immune-based cancer therapeutics, understanding cancer treatment responses, and the dynamics of cancer progression. His contributions to the field are marked by a relentless pursuit of knowledge and a passion for discovering mechanism-informed therapies that can transform the landscape of cancer treatment. Through his innovative research and dedication to the field of biomedical engineering, Dr. Yong Teng continues to make significant strides in the fight against cancer, striving to develop therapies that not only treat the disease but also empower the body's natural defenses to combat it. His work exemplifies the potential of interdisciplinary collaboration in addressing some of the most pressing challenges in modern medicine.